Every year, new officers are selected to serve a three-year term on the ONS Board of Directors. Interested candidates are welcome to reach out to the current members of the ONS Board of Directors to better understand these commitments on a more individualistic level.
Director-at-Large (2023–2026)
Glendora, CA
Director-at-Large (2023–2026)
Madison, MS
Director-at-Large (2023–2026)
Coral Gables, FL
The Leadership Development Committee consists of seven members, appointed by the ONS Board of Directors, who oversee all of ONS's leadership development initiatives. The committee's objectives are to:
Committee Chair (2023-2025)
Committee Member (2022-2025)
Waukesha, WI
jeanie@wi.rr.com
Jeanie Rosiak has been an ONS member for over 45 years. She has held various leadership positions in ONS including Steering Council member and chair, Nominating Committee member and chair, and Director-at-Large on the ONS Board. Jeanie works as a Nurse Practitioner in a Comprehensive Breast Center in Milwaukee, Wisconsin.
Committee Member (2023 - 2026)
Marietta, GA
mfgulla@emory.edu
Mary Magee Gullatte, PhD, RN, ANP-BC, AOCN, LSSYB, FAAN is presently the Corporate Director of Nursing Evidence Based Practice and Research at EMORY Healthcare, in Atlanta. Her leadership in nursing spans over 44 years with extensive experience in Oncology Nursing, Administration & Leadership.
Dr. Gullatte is Adjunct Faculty at the Emory University Nell Hodgson Woodruff School of Nursing. She is also a USAF veteran. As a Nurse Practitioner, her focus is on Primary care of the adult population. She served 7 years as Vice President of Patient Services and Chief Nursing Officer at Emory University Hospital Midtown, Atlanta, Georgia. Mary is the past president of the National Oncology Nursing Society from 2012 – 2014 (nearly 40,000 members). She has presented at numerous national and international conferences representing 6 of the 7 continents: including, invited speaker and oncology nurse consultant in West Africa; Prague, Czech Republic, Germany, Norway, Australia, Brazil, Amsterdam, Turkey, Oman-UAE, Thailand, China, United Kingdom, Brussels, France, Philippines, and New Zealand.
Dr. Gullatte has contributed extensively to the body of published professional literature through articles and textbooks. Her recent books, 21st Century Nursing Leadership was awarded book of the Year in 2018 by the American Journal of Nursing and Mary is the lead editor of Chemotherapy Handbook currently 4th edition published in March 2020 by the Oncology Nursing Society. Throughout her career, Dr. Gullatte has received awards from the Oncology Nursing Society, the Georgia Nurses Association, Chi Eta Phi Nursing Sorority, American Cancer Society, the Greater Atlanta Affiliate of Susan G. Komen, Atlanta Black Nurses Association, community service award from Delta Sigma Theta Sorority and the 2020 Distinguished Nurse of the Year from the Atlanta March Of Dimes. Dr. Gullatte is a member of Sigma Theta Tau and was inducted into the American Academy of Nursing in 2010 and elected to the Board two terms 2018-2022.
She served on the Joint Commission Nursing Advisory Board until 2019. She currently serves on the board of the Nursing Services Organization and Georgia Nurses Foundation Trustee. Led the GNA/GNF Task Force to develop a Policy Brief on Advancing Health Equity in Georgia; published Sept. 2022. Dr. Gullatte is the executive sponsor and founder of the Emory Nurse Health Policy, Legislative, and Advocacy Council. She enjoys mentoring, empowering, and inspiring future generations of nurses to aspire to and achieve greatness beyond what they have imagined. Her professional passion is transforming healthcare to prevent disease and improve patient and provider outcomes and wellbeing.
Committee Member (2023 - 2026)
Midlothian, VA
Karen.roesser@hcahealthcare.com
Karen Roesser has been an ONS member since 1983. She is the Administrative Director of the Sarah Cannon Cancer Institute at Johnston-Willis Hospital in Richmond, Virginia. She has served ONS in multiple roles including as Associate Editor of the ONS Website, ONS Abstract Reviewer, and on the ONCC Recognition Committee. She has published extensively and has presented on numerous occasions at ONS Congress. She has represented ONS internationally teaching nurses in Russia and Thailand. She is the recipient of the Advanced Oncology Certified Nurse of the Year award and the ONS Mary Nowotny Excellence in Cancer Nursing Education award.
Committee Member (2023 - 2026)
Stonington, CT
nancy.houlihan@gmail.com
Nancy G. Houlihan has been an oncology nurse for over 40 years, working in advanced practice and progressive leadership roles at Memorial Sloan Kettering Cancer Center, most recently serving as Director of Nursing for Evidence-based Practice and member of the Executive Leadership Team. She has participated in various roles in ONS over the last 20 years, serving on the New York City chapter Board, Nominating Committee, editorial board for Oncology Nursing Forum, Congress Planning Committee, Board of Directors and President of the Board, 2020-2022. She has received various awards including the ONS Lifetime Achievement Award and has been inducted into the Alumni Association Hall of Fame of Hunter College of the City University of New York.
Committee Member (2021 - 2024)
Tappan, NY
adjetey.appiah@gmail.com
Angela Adjetey Appiah has been a member of ONS since 1998. She is a member of the ONS Leadership Development Committee. Angela was one of the founding members of the Rockland County ONS chapter and has served both locally and nationally on different ONS engagements. Angela has been in oncology nursing for over 21 years in various roles. She represents oncology nursing on other global forums such as ISNCC and ICEC. She has presented and published extensively on various topics.
Committee Member (2021 - 2024)
Rockville, MD
agalassi57@gmail.com
Annette Galassi, RN, MA, OCN has spent her entire 40-plus year career in oncology and almost as long as an ONS member. She has held positions in clinical practice, professional education, clinical research, program development and evaluation. She is currently a nurse consultant for the Center for Global Health at the US National Cancer Institute (NCI).
In addition to serving on the ONS Leadership Development Committee, Ms. Galassi has served as a reviewer and as associate editor for the Clinical Journal of Oncology Nursing (CJON), and as a member of the ONS Global Oncology Think Tank. She has completed several assignments with Health Volunteers Overseas (HVO) in Ethiopia, Bhutan and Vietnam and currently chairs the HVO Oncology Steering Committee. Ms. Galassi has published numerous articles and chapters about oncology nursing, clinical trials, cancer control, and global oncology. Her awards include the NIH Merit Award, Georgetown University’s Nurse of the Year and HVO’s Golden Apple Award.
Committee Member (2022-2025)
Louisville, KY
mtkdnp67@twc.com
Monica Key has been an ONS member since 2008 and is the Program Manager for the global oncology ARIA Program at St. Jude Children’s Research Hospital. She has served ONS in numerous volunteer and consulting roles in the past. Monica is a published author in various peer-reviewed health care journals. Has served as an expert content writer/editor and professional speaker for various organizations. Received many local and national awards for contributions in health care and community service. She is an experienced oncology health care professional with 20+ year prior career in business administration advising national, regional and local organizations as well as possessing over a decade of experience in direct oncology patient care as a dual-certified oncology nurse practitioner.
You can become part of the vital group of leaders who shape the future of ONS. Each year, positions are available for candidates for our nationally elected office. Learn more about our slating process below and on our Leadership Pathway.
The first step in applying to be considered for the ONS Board of Directors is to complete a notification of intent (NOI). The Leadership Development Committee (LDC) will review your NOI and be in contact with you in regards to completing a full application. Please do not complete a full application unless directed by the LDC to do so.
An LDC member will contact you in regards to your NOI. If invited to apply, you will submit a full application. The application is due January 10, 2024 and includes:
Your full application and interview are reviewed by the LDC. All candidates are scored on a standardized rubric, and skills, qualifications, and experiences are weighed against the needs of the Board of Directors and the Society.